Application and Technical Notes
Application Notes
- APPLICATION NOTE 1: See What’s Really In Your Formulation With Backgrounded Membrane Imaging
- APPLICATION NOTE 2: Accurate Subvisible Particle Analysis With 10x Less Sample
- APPLICATION NOTE 3: Washing for More Accurate Particle Counts
- APPLICATION NOTE 4: Sized Right For Particle Analysis
- APPLICATION NOTE 5: High Throughput Measurement of Compound Solubility and Physical Form with BMI
- APPLICATION NOTE 6: Are You Missing the Bigger Picture with Your AAV Analytics?
- APPLICATION NOTE 7: Protein Aggregate Identification with FMM: Rapidly Distinguish Protein from Non-Protein Particles in Biologic Formulations
- APPLICATION NOTE 8: AAV Aggregate Quantitation and Identification with the Aura System
- APPLICATION NOTE 9: USP Compendial Particle Measurements with the Aura System
- APPLICATION NOTE 10: Detect Specific Protein Aggregates in Biologic Formulations with the Aura Immunoassay
- APPLICATION NOTE 11: High-Throughput Detection of Degraded Polysorbate in Biological Formulations with FMM
- APPLICATION NOTE 12: Detect, Identify, and Characterize Cellular versus Non-cellular Aggregates with the Aura CL
- APPLICATION NOTE 13: Evaluate Cell Therapy Product Purity with Aura CL
- APPLICATION NOTE 14: Identify and Characterize Particles in the Visible Size Range with Aura
- APPLICATION NOTE 15: Accurate, High-Throughput Cell Viability and Purity Measurements with Aura CL
- APPLICATION NOTE 16: Is Your AAV Payload Impacting Stability? Find Out With Aura GT
- APPLICATION NOTE 17: Identify Optimal Biologic Candidates: Low Volume, Early Stage Developability Assessment with Aura PTx
- APPLICATION NOTE 18: Identify Stable Biologic Candidates During Cell Line Development With Aura PTx
- APPLICATION NOTE 19: Analysis of Subvisible and Visible Aggregation in Lentiviral Vectors with Aura GT
- APPLICATION NOTE 20: Accurate Particles Characterization in Lipid Nanoparticle Therapies
- APPLICATION NOTE 21: Subvisible Particles: Why Don’t I Just Filter My Biologic Samples?